Skip to content

Rehabilitation of Patients From the ICU to the Post-hospital Phase

Rehabilitation of Patients Submitted to Mechanical Ventilation, From the ICU to the Post-hospital Phase: Blinded Randomized Controlled Clinical Trial, With Economic and Multicenter Evaluation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06405529
Enrollment
206
Registered
2024-05-08
Start date
2024-07-01
Completion date
2027-01-31
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Mobilization, Physiotherapy, Rehabilitation

Keywords

Mechanical ventilation, Physiotherapy, Respiratory function, Functional capacity, Rehabilitation, Cost-effectiveness

Brief summary

Introduction: Advances in knowledge have contributed to the increase in the number of patients who survive prolonged hospitalization in an Intensive Care Unit (ICU), and, among them, critically ill patients who develop acute respiratory failure and need for mechanical ventilation. These individuals have their mobility restricted to bed, and may suffer from pulmonary and systemic complications, such as ICU-Acquired Muscle Weakness, which increases the chances of resulting in reduced functional capacity or death. Early mobilization in the ICU has demonstrated benefits, but still with a low level of evidence. However, the type and intensity of exercise still need to be better defined, and previous protocols did not offer continuous monitoring from the ICU to the ward and subsequent outpatient rehabilitation for these patients, which is considered a limitation in some studies. Objective: To investigate the effects of an early and intensive hospital mobilization and post-hospital rehabilitation program on indicators of functionality, inflammation, cost-effectiveness, and mortality in critically ill patients undergoing invasive mechanical ventilation. Methods: This is a Blind Randomized Controlled Clinical Trial that will be conducted in the ICUs of the Hospital das Clinicas and the Emergency Unit of the Faculty of Medicine of Ribeirao Preto of the University of São Paulo. Patients of both sexes over 21 years of age who have been under invasive mechanical ventilation for at least 24 hours will be recruited. Patients will be randomized into the Intervention Group (IG), with 30 to 60 minutes of exercise per day, and the Control Group (CG), with 10 minutes of exercise per day, both with the same protocol and based on the ICU Mobility Scale - IMS, with continuity in the ward. After hospital discharge, participants will be allocated to the Guidance Group (GIor and GCor) and the Outpatient Rehabilitation Group (GIreab and GCreab), with functional exercise capacity as the main outcome, assessed by the six-minute walk test (6MWT). Volunteers will be monitored one, three, and six months after hospital discharge. The sample calculation was based on the results of the 6MWT , with a power of 80% for the assessments carried out at the proposing institution (n=206), and with a power of 90% for the multicenter project (n=275), considering a sample loss of 30%. The following will be evaluated: clinical parameters, severity indexes, functionality, lung function and mechanics, functional exercise capacity, mortality, inflammatory markers, energy expenditure, activities of daily living, quality of life, muscle assessment, adherence, barriers and facilitators and cost-effectiveness.

Interventions

OTHEREarly and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge

During hospitalization in the ICU and ward, you will perform 30 to 60 minutes of exercises per day, according to the IMS scale. After hospital discharge, participation in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center - CER of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Both sexes * Age greater than or equal to 21 years * Be on invasive mechanical ventilation (IMV) for at least 48 hours * Sufficient cardiovascular stability for mobilization 1. Absence of bradyarrhythmia (\< 50 bpm); 2. Heart rate ≥ 150 bpm; 3. Most recent lactate measurement ≤ 4.0mmol/L; 4. Combined adrenaline/noradrenaline infusion rate ≤ 0.2mcg/Kg/min, OR if the adrenaline/noradrenaline infusion was increased by more than 25% in the last 6 hours; 5. Cardiac index ≥ 2.0L/min/m2; when evaluated * Respiratory stability sufficient for mobilization f) Respiratory rate ≤ 45rpm; g) FiO2 ≤ 0.6; h) PEEP ≤ 16 cmH2O; i) No need for NO (nitric oxide), prone position, neuromuscular blocker, ECMO (extracorporeal membrane oxygenation) or HFOV (high frequency ventilation).

Exclusion criteria

* Dependent for ADLs in the month prior to ICU admission; * Diagnosed cognitive deficit; * Diagnosis OR suspicion of acute primary brain disease (TBI, stroke); * Diagnosis OR suspected spinal cord injury OR other neuromuscular disease that may result in prolonged or permanent muscle weakness (except muscle weakness acquired in the ICU); * Need OR instructions to remain in bed OR not to bear weight on the lower limbs bilaterally; * Life expectancy of less than 180 days due to acute or chronic clinical conditions; * Death considered inevitable due to current clinical condition or if the patient/clinical guardian is not committed to complete active treatment (e.g. brain death); * Inability to communicate in Portuguese; * Readmission to the ICU of the same hospital service; * Pregnant women; * Patients with a permanent pacemaker.

Design outcomes

Primary

MeasureTime frameDescription
Functional exercise capacityThrough study completion, an average of 5 yearAssessed by the 6-minute walk test

Secondary

MeasureTime frameDescription
Pulmonary functionThrough study completion, an average of 5 yearSpirometry will be used as a tool to assess the lung function. The test will be performed by every volunteer and the measurement will be done by guidelines of the Brazilian Society of Pulmonology and Phthisiology for lung function tests.
MortalityThrough study completion, an average of 5 year
Cost-effectiveness12 months after study completionEconomic evaluation - Patient and Institution costs
Clinical parametersThrough study completion, an average of 5 yearHemodynamic data will be evaluated beafore and after the mobilization protocol
Severity indexesThrough study completion, an average of 5 yearAcute Physiologic and Chronic Health Evaluation II Score (APACHE II). This tool assesses the severity of the disease and mortality of patients admitted to the ICU, consisting of 12 variables that include: age, past medical history, as well as clinical and physiological indices.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026